Furthermore, considering the widespread dysregulation of KRT80 and the emerging evidence supporting the tumor-suppressive role of miR-195-5p in multiple cancer types [31], this therapeutic strategy holds strong potential for broader oncological applications, extending beyond colorectal cancer to other malignancies characterized by similar molecular alterations. This evidence concerns the gene KRT80 and colorectal cancer.